Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
Kishan L Asokan,Jennifer R Landes,Wannes Renders,Laura Muiño Mosquera,Julie De Backer,David W Jantzen,Anji T Yetman,Gisela Teixido-Tura,Arturo Evangelista,Richmond Jeremy,Edward G Jones,Shaine Morris,Tam Doan,Maral Ouzonian,Alan Braverman,Guillaume Jondeau,Olivier Milleron,Dianna M Milewicz,Siddharth K Prakash,Montalcino Aortic Consortium *,Ellen Regalado,Anthony L Estrera,David R Murdock,Laura Muiño-Mosquera,Anne De Paepe,Bert Callewaert,Marjolijn Renard,Patrick Sips,Anji Yetman,Lois Starr,Anna Sabaté Rotés,Catherine Boileau,Milleron Olivier,Claire Bouleti,Nadine Hanna,Carine Le Goff,Quentin Pellenc,Lesley Ades,Maral Ouzounian,David Chitayat,Takayuki Morisaki,Hiroko Morisaki,Ismail El-Hamamsy,Francesco Ramirez,Yskert von Kodolitsch,Meike Rybczynski,Ronald Lacro,Michael N Singh,George Sandor,Derek Human,Pascal-Nicoloas Bernatchez,Reed Pyeritz,Joseph Bavaria,Scott Michael Damrauer,Mary B Sheppard,Apostolos Psychogios,Nanette Alvarez,Julien Marcadier,Michelle Keir,David Liang,Seda Tierney,Mirela Tuzovic,Sara B MacKay,Andrea L Rideout,Sandhya Parkash,Antho Ny Martin Vandersteen,Marion A Hofmann-Bowman,Bo Yang,Vidyasagar Kalahasti,Justin T Tretter,Scott A LeMaire,Justin A Weigand,Taylor A Beecroft,Sherene Shalhub,David Dichek,Juan Manuel Bowen,Talha Niaz,Shaine A Morris,Eloisa Arbustini,Anne Child,Bo Carlberg,Richard B Devereaux,Bridgete Fernandez,Josephine Grima,Maarten Groenink,Gabrielle Horne,Alex V Levin,Irene Maumenee,Vivienne McConnell,Rocio Moran,Alex Pitcher,Nancy Poirier,Peter Robinson,Dieter Reinhardt,Lynn Sakai,Denver Sallee,Fabien Labombarda,Laurence Faivre,Zoltan Szabolcs,Andrew Michael Crean,Philip Giampietro,Mark Evan Lindsay,Shuping Ge,Anthony Caffarelli,Jolien Roos-Hesselink,Andrew Choong,Enid Neptune,Zhou Zhou,Alessandro Pini,Germano Melissano,Elisabetta M Mariucci,Elena Cervi,Melissa L Russo,Mitra Esfandiarei,Jessica Wang,Kevin Michael Harris,Jay B Shah,Irman Forghani,Kelly Cox,Sachiko Kanki,Alan Frederick Rope,Yaso Emmanuel,Klaus Kallenbach,Timothy Carter,Martin Czerny,Brett Carroll,William T Brinkman,Christopher Phillips Jordan
DOI: https://doi.org/10.1161/JAHA.124.036274
2024-11-05
Abstract:Background: Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a cross-sectional analysis of 2014-2023 data in the Montalcino Aortic Consortium registry. Methods and results: MAD was determined by direct measurement of echocardiographic images. MR and MVP were defined according to current clinical guidelines. Associations were evaluated using χ2 or Fisher exact tests. MR and MVP were enriched in Montalcino Aortic Consortium participants (672) with pathogenic variants (PV) in transforming growth factor-β pathway genes. The combination of MR and MVP was associated with mitral surgery and arrhythmias. In the subgroup with available images, MAD was enriched in SMAD3 PV compared with other transforming growth factor-β PV (prevalence ratio 1.8 [1.1-2.8], P <0.02). Severe disjunction (>10 mm) was only observed in the transforming growth factor-β subgroup and was further enriched in participants with SMAD3 PV (prevalence ratio 3.1 [1.1-8.6]). MVP (prevalence ratio 5.2 [3.0-9.0]) and MR (PR 2.7 [1.8-3.9]) were increased in participants with MAD, but MAD was not independently associated with adverse cardiac or aortic events. Conclusions: Pathological mitral valve phenotypes are more prevalent in individuals with PV in transforming growth factor-β pathway genes, particularly SMAD3. MR and MVP but not MAD are associated with adverse aortic and cardiac events. Because congenital mitral disease may be the primary presenting feature of SMAD3 PV, genetic testing for heritable thoracic aortic disease should be considered for such individuals, especially if they also have a family history of heritable thoracic aortic disease.